Clinical Research Directory
Browse clinical research sites, groups, and studies.
Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors
Sponsor: University of Alabama at Birmingham
Summary
The focus of this research is on increasing the uptake of the human papillomavirus (HPV) vaccine in young cancer survivors, a vulnerable population at high risk for developing new cancers (such as cervical and anal cancer) caused by persistent HPV infection. An effective vaccine exists that can prevent these cancers, but HPV vaccine uptake is low among young cancer survivors. This research will evaluate the effectiveness and implementation of an evidence-based intervention, adapted for use by healthcare providers in pediatric oncology clinics, to increase the uptake of HPV vaccine among young cancer survivors 9-17 years of age. Results of this research will provide important information that can be used to implement new strategies to increase the uptake of the HPV vaccine among young cancer survivors.
Official title: Implementation of a Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors Receiving Follow-Up Care in Pediatric Oncology Practices: A Cluster-Randomized Trial
Key Details
Gender
All
Age Range
9 Years - Any
Study Type
INTERVENTIONAL
Enrollment
5196
Start Date
2021-02-01
Completion Date
2026-01-31
Last Updated
2025-02-03
Healthy Volunteers
No
Conditions
Interventions
HPV-PROTECT
HPV-PROTECT is a multicomponent provider-focused intervention specifically tailored for use in pediatric oncology settings, addressing important survivor-specific vaccine issues. The intervention is comprised of three components, i) Provider Communication Training; ii) Assessment and Peer Feedback/ Coaching; and iii) Provider Toolkit. The HPV-PROTECT intervention is designed to increase provider knowledge regarding use of the HPV vaccine in the cancer survivor population, enhance provider skills in delivering brief, compelling HPV vaccine recommendations to parents of young cancer survivors, present ongoing feedback to providers regarding clinic- and provider-level survivor HPV vaccination rates, and decrease barriers to receipt of vaccine by survivors through the provision of Vaccine Action Plans, tailored to local context.
Locations (6)
University of Alabama at Birmingham
Birmingham, Alabama, United States
Emory University
Atlanta, Georgia, United States
University of Minnesota
Minneapolis, Minnesota, United States
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
Oregon Health and Science University
Portland, Oregon, United States
Baylor College of Medicine
Houston, Texas, United States